Question:

A 10-year-old child with chronic kidney disease develops persistent hyperkalemia despite dietary potassium restriction. Which of the following is the most likely mechanism?

Show Hint

Type 4 RTA Mechanism: Juxtaglomerular disease in CKD $\rightarrow$ $\downarrow$ Renin $\rightarrow$ $\downarrow$ Aldosterone (Hyporeninemic Hypoaldosteronism) $\rightarrow$ Hyperkalemia + Normal Anion Gap Metabolic Acidosis.
Updated On: Sep 3, 2026
  • Hyporeninemic hypoaldosteronism
  • Volume overload and hypertension
  • Fibroblast Growth Factor 23 (FGF-23)
  • Metabolic acidosis
Show Solution
collegedunia
Verified By Collegedunia

The Correct Option is A

Solution and Explanation

Concept:
Potassium homeostasis in chronic kidney disease (CKD) is tightly regulated by aldosterone-mediated potassium secretion in the cortical collecting duct principal cells via ROMK and BK channels.
Impairment in the renin-angiotensin-aldosterone axis commonly leads to out-of-proportion hyperkalemia and non-anion gap metabolic acidosis (Type 4 Renal Tubular Acidosis).
Explanation:
• In chronic kidney disease, tubulointerstitial injury and arteriolar hyalinosis characteristically damage the juxtaglomerular apparatus, impairing the production and release of active renin.

• The resulting state of hyporeninemic hypoaldosteronism (Type 4 RTA) causes deficient aldosterone synthesis by the adrenal zona glomerulosa.

• Aldosterone deficiency reduces the activity of the basolateral $Na^+/K^+$-ATPase and decreases apical epithelial sodium channels (ENaC) and renal outer medullary potassium (ROMK) channels in the collecting tubule.

• This impairs electrical driving forces and prevents tubular potassium excretion, resulting in persistent hyperkalemia even with modest reductions in GFR and strict dietary potassium restriction.

• FGF-23 is a phosphaturic hormone secreted by osteocytes that increases urinary phosphate excretion and downregulates $1\alpha$-hydroxylase, playing no direct role in primary potassium retention.

• While metabolic acidosis causes an extracellular shift of potassium, chronic persistent baseline hyperkalemia in tubulointerstitial CKD is primarily driven by hyporeninemic hypoaldosteronism.
Final Answer:
The most common underlying endocrine/tubular mechanism for persistent hyperkalemia in pediatric CKD is hyporeninemic hypoaldosteronism (Type 4 RTA).
Was this answer helpful?
0
0

Top NEET SS Paediatrics Questions

View More Questions

Top NEET SS Questions

View More Questions